|
Multimedia
Images, audio, and video related to cancer research
Calendar
Meetings, seminars, and press conferences focused on cancer research
Resources
Information on cancer types, treatment, prevention, and more
![]() Sponsored by: The Cancer News Portal is supported by the National Cancer Institute of the National Institutes of Health. Additional information on cancer research, prevention, and treatment is available at www.cancer.gov |
Breaking News
Key: Meeting
Showing releases 126-150 out of 1124. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>
Public Release: 13-Nov-2012
A sip of resveratrol and a full p53: Ingredients for a successful cell death Researchers at the Universidade Federal in Rio de Janeiro in Brazil have found that introduction of a normal copy of the p53 gene in p53-defective cancer cell lines makes these cells sensitive to the anti-tumor proprieties of resveratrol, the naturally occurring dietary compound found in red wine. Contact: Jerson Lima Silva Public Release: 13-Nov-2012
Stereoscopic mammography could reduce recall rate A new three-dimensional digital mammography technique has the potential to significantly improve the accuracy of breast cancer screening. Contact: Linda Brooks Public Release: 13-Nov-2012
Cancer: Exercise reduces tiredness Aerobic exercise can help relieve the fatigue often associated with cancer and cancer treatment, according to Cochrane researchers. Their updated systematic review strengthens findings from an earlier version on cancer-related fatigue published in the Cochrane Library Contact: Ben Norman Public Release: 13-Nov-2012
Terminally ill cancer patients who discuss end-of-life care early can avoid aggressive treatment Terminally ill cancer patients who have an early talk with their physician about care at the end-of-life are less likely to receive aggressive therapy – and more likely to enter hospice care – than patients who delay such discussions until the days and weeks before death, a new study by Dana-Farber Cancer Institute researchers suggests. Contact: Anne Doerr Public Release: 13-Nov-2012
Scientists discover how stomach cancer spreads Scientists at the University of Liverpool have found that the production of a protein that prevents the growth and spread of cancerous cells is impaired in patients with gastric cancer. Contact: Samantha Martin Public Release: 12-Nov-2012
Awareness could eliminate inequalities in cancer diagnoses There are substantial inequalities in the stage at which cancer patients receive their diagnosis -- a critical factor for cancer survival -- a new study by the University of Cambridge reveals. The researchers found that age, sex and income as well as the type of cancer influenced the risk of a patient being diagnosed at an advanced stage of the disease. Contact: Genevieve Maul Public Release: 12-Nov-2012
New studies shed light on what it cost to vaccinate girls against HPV in low income countries Two studies published in BioMed Central's open access journal BMC Medicine examined the cost of delivering the human papillomavirus (HPV) vaccine to primary school girls in Tanzania. Both studies found that the cost of HPV vaccine delivery to adolescent girls may be substantially higher compared with the cost of delivering a new vaccine to an infant where the delivery schedule matches the existing infant immunization schedule. Contact: Hilary Glover Public Release: 12-Nov-2012
JCI early table of contents for Nov. 12, 2012 This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Nov. 12, 2012, in the JCI: Home field advantage: Intravaginal immunization may help protect against infection; HIV-1 vaccine development: pinning down a moving target; Researchers find abnormal dopamine signaling in a mouse model of Angelman's syndrome; A new view of the immune system; Unraveling the role of the unfolded protein response in cancer; and many more. Contact: Jillian Hurst Public Release: 12-Nov-2012
Study shows how chronic inflammation can cause cancer A new study has found that interleukin-15 (IL-15) alone can cause large granular lymphocytic (LGL) leukemia, a rare and usually fatal form of cancer. The researchers developed a treatment for the leukemia that showed no discernible side effects in an animal model. The study shows that IL-15 is also overexpressed in patients with LGL leukemia and that it causes similar cellular changes, suggesting that the treatment should also benefit people with the malignancy. Contact: Darrell E. Ward Public Release: 12-Nov-2012
November/December 2012 Annals of Family Medicine tip sheet This tip sheet offers synopses of original research and editorials included in the November/December 2012 issue of Annals of Family Medicine research journal. Contact: Angela Sharma Public Release: 12-Nov-2012
Black patients with kidney cancer have poorer survival than whites Among patients with the most common form of kidney cancer, whites consistently have a survival advantage over blacks, regardless of patient and tumor characteristics or surgical treatment. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study's results suggest that additional efforts are needed to prolong the survival of all patients with kidney cancer. Contact: Amy Molnar Public Release: 12-Nov-2012
Catch and release A research team at Brigham and Women's Hospital has developed a novel device that may one day have broad therapeutic and diagnostic uses in the detection and capture of rare cell types, such as cancer cells, fetal cells, viruses and bacteria. Contact: Marjorie Montemayor-Quellenberg Public Release: 12-Nov-2012
Gene sequencing project identifies abnormal gene that launches rare childhood leukemia Research led by the St. Jude Children's Research Hospital -- Washington University Pediatric Cancer Genome Project has identified a fusion gene responsible for almost 30 percent of a rare subtype of childhood leukemia with an extremely poor prognosis. Contact: Summer Freeman Public Release: 12-Nov-2012
New statistical method offers automatic mitotic cell detection for cancer diagnosis Scientists have developed a statistical image analysis method which can assist in the grading of breast cancer by automatically segmenting tumour regions and detecting dividing cells in tissue samples. Contact: Anna Blackaby Public Release: 12-Nov-2012
Duke Medicine news -- Genome sequencing of Burkitt Lymphoma reveals unique mutation In the first broad genetic landscape mapped of a Burkitt lymphoma tumor, scientists at Duke Medicine and their collaborators identified 70 mutations, including several that had not previously been associated with cancer and a new one that was unique to the disease. Contact: Sarah Avery Public Release: 12-Nov-2012
UT Arlington physics team demonstrates new power generation technique University of Texas at Arlington and Louisiana Tech University researchers created a hybrid nanomaterial that can be used to convert light and thermal energy into electrical current. The team built a prototype thermoelectric generator they hope can eventually produce milliwatts for use in devices such as self-powering sensors, low-power electronic devices and implantable biomedical micro-devices, they said. UT Arlington's Wei Chen has also coupled gold nanoparticles with copper sulfide nanoparticles for potential use in cancer therapy. Contact: Traci Peterson Public Release: 12-Nov-2012
Scientists at IRB BARCELONA discover a key process that allows colon cancer to metastasize Researchers at the IRB Barcelona have determined that the ability of colon cancer to metastasize lies in the healthy cells, called stroma, that surround the tumor. Although the stroma has long been hypothesized to be complicit in this process, this study marks the first time that healthy cells in the microenvironment have been observed to play a fundamental role in allowing metastasis to occur in a specific tumor type. Contact: Sònia Armengou Public Release: 12-Nov-2012
Place in the sun carries risks for outdoor workers Those individuals who work outdoors with resultant sun exposure are at increased risk for non-melanoma skin cancers, such as squamous cell carcinoma and basal cell carcinoma. Manige Fartasch shows that the connection between occupational UV exposure and squamous cell carcinoma is now well-established in her review article in issue 43 of Deutsches Arzteblatt International. Contact: Manigé Fartasch Public Release: 12-Nov-2012
PI3-kinase and PARP inhibitor combo may offer new treatment option for triple-neg breast cancers PI3-kinase inhibitors sensitized tumors to PARP inhibitors. Combination significantly prolonged progression-free survival in mouse model. Contact: Jeremy Moore Public Release: 11-Nov-2012
Detection, analysis of 'cell dust' may allow diagnosis, monitoring of brain cancer A novel miniature diagnostic platform using nuclear magnetic resonance technology is capable of detecting minuscule cell particles known as microvesicles in a drop of blood. Microvesicles shed by cancer cells are even more numerous than those released by normal cells, so detecting them could prove a simple means for diagnosing cancer. Contact: Sue McGreevey Public Release: 11-Nov-2012
Gene variations linked to lung cancer susceptibility in Asian women An international group of scientists has identified three genetic regions that predispose Asian women who have never smoked to lung cancer. The finding provides further evidence that risk of lung cancer among never-smokers, especially Asian women, may be associated with certain unique inherited genetic characteristics that distinguishes it from lung cancer in smokers. Contact: NCI Press Office Public Release: 9-Nov-2012
New mechanism of action for PARP inhibitors discovered PARP inhibitors are promising treatments for BRCA-mutant breast and ovarian cancers. Researchers have identified a new way in which these drugs work. New genetic mutations rendering cells susceptible to PARP inhibitors are also identified. Patients with tumors bearing these mutations might benefit from PARP inhibitors. Contact: Jeremy Moore Public Release: 9-Nov-2012
Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors Researchers at Moffitt Cancer Center have identified metabolic signatures that may pave the way for personalized therapy in glioma, a type of tumor that starts in the brain. Contact: Kim Polacek Public Release: 9-Nov-2012
A comparative medicine study by Penn vet identifies a new approach to combat viral infections When a virus such as influenza invades our bodies, interferon proteins are among the first immune molecules produced to fight off the attack. A study by scientists from the University of Pennsylvania School of Veterinary Medicine offers a new strategy for enhancing the effects of interferon in fighting off infection. Contact: Katherine Unger Baillie Public Release: 9-Nov-2012
Compound in grapes, red wine could be key to fighting prostate cancer A University of Missouri researcher has discovered that the compound can make prostate tumor cells more susceptible to radiation treatment, increasing the chances of a full recovery from all types of prostate cancer, including aggressive tumors. Contact: Christian Basi
Showing releases 126-150 out of 1124. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>
|
Search News Releases
|
|||||||||||||||||||||||||